Furthermore, we investigated whether KW-2478 could increase the sensitivity of CML cells to imatinib and whether KW-2478 could overcome the imatinib resistance caused by BCR/ABL amplification. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.